Event Date/Time: Sep 10, 2008
End Date/Time: Sep 11, 2008
Sep 09, 2008
Early Registration Date:
Jun 23, 2008
The future of the pharmaceutical industry lies with biotechnology. Biotech drugs account for around 10-15% of the current pharmaceutical market, and the sector is outperforming the market as a whole in terms of growth. With increasing regulatory clarity and the expiries of key patents covering innovator biologics, the development of biosimilars for a range of recombinant protein classes is becoming increasingly attractive.
The 2nd annual Biosimilars Conference will bring experts from the industry and academy sector together to discuss the latest developments in biosimilars regulations, clinical assessment, manufacturing processes and pricing and reimbursement. Through a series of presentations and interactive discussions, participants will gain new insight and share hands-on experiences in the latest trends and practices in the development of biosimilars.
All three days â€“ two day conference and pre conference workshop Â£1898 + VAT@16 = Â£2201.68*
The two day conference Â£1299 +VAT@16 = Â£1506.84*
The pre conference workshop
Â£699 +VAT@ 17.5 + Â£810.84*
If you cannot attend the conference but would like to receive
the documentation Â£299